Treatment of idiopathic restless legs syndrome (RLS) with slow-release valproic acid compared with slow-release levodopa/benserazid: A randomized, placebo-controlled, double-blind, cross-over study

By Eisensehr Ilonka   Ehrenberg Bruce   Rogge Solti Silvia   Noachtar Soheyl  

Journal of Neurology, Vol. 251, Iss. 5, 2004-05 ,pp. : 579-583

Springer Publishing Company

Access to resources Recommend Favorite

Treatment of spasticity with repetitive magnetic stimulation; a double-blind placebo-controlled study

By Nielsen J.F.   Sinkjaelig r T.   Jakobsen J.  

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 142-142

Elsevier

Access to resources Recommend Favorite

Botulinum toxin type-A in the prophylactic treatment of medication-overuse headache: a multicenter, double-blind, randomized, placebo-controlled, parallel group study

By Sandrini Giorgio  

The Journal of Headache and Pain, Vol. 12, Iss. 4, 2011-08 ,pp. : 427-433

Springer Publishing Company

Access to resources Recommend Favorite

EHT0202 in Alzheimer's Disease: A 3-Month, Randomized, Placebo- Controlled, Double-Blind Study

By  

Current Alzheimer Research, Vol. 8, Iss. 2, 2011-03 ,pp. : 203-212

Bentham Science Publishers

Access to resources Recommend Favorite

A double-blind, randomized, placebo-controlled, parallel-group study of Sativex, in subjects with symptoms of spasticity due to multiple sclerosis

By Collin C.   Ehler E.   Waberzinek G.   Alsindi Z.   Davies P.   Powell K.   Notcutt W.   O'Leary C.   Ratcliffe S.   Nováková I.   Zapletalova O.   Piková J.   Ambler Z.  

Neurological Research, Vol. 32, Iss. 5, 2010-06 ,pp. : 451-459

Maney Publishing

Access to resources Recommend Favorite